Implementing a System-wide 340B Program
|
|
- Verity Merritt
- 8 years ago
- Views:
Transcription
1 Implementing a System-wide 340B Program An Overview Steve Pitzer System Executive, Supply Chain Management CHRISTUS Health Sam Colletti, RPh Director of Enterprise Accounts- CHRISTUS Health Broadlane
2 Objectives CHRISTUS Supply Chain Management Review of 340B Program CHRISTUS Implementation of a System-Wide 340B Program Indentifying appropriate Staff, Departments, resources Identify challenges and prohibitions to facilities Tracking results Update of Current Legislative Activity and Implications to Eligible Healthcare Facilities
3 CHRISTUS Health Supply Chain in Collaboration with Broadlane and Supplier Partnerships Steve Pitzer, System Director Supply Chain Management
4 CHRISTUS Health 1999 two historic Catholic charities formed CHRISTUS Health: Sisters of Charity Health Care System Incarnate Word Health System Mission: To extend the healing ministry of Jesus Christ Top 10 Catholic health system in U.S. 43 hospitals / 16 long-term acute care facilities across 8 states and Mexico Net patient revenues exceeding $2.6 billion Charity Care Community Benefit 2.8 million Assets totaling more than $4.3 billion Supplies, Purchased Services, and Energy $957million 4 Confidential Not For Distribution
5 Supply Chain Collaboration Quality & Safety Savings = Savings RASMUS Information Management variability = predictable outcomes Waste leads to risk MD s and stakeholders Listen and educate High value vs. Low impact Multi-disciplinary Educational Clinical & Non-Clinical Committees Pharmacy & Nursing Flexible Multi-disciplinary Physician preference items 5 Confidential Not For Distribution
6 CHRISTUS Health Committee collaboration 6 Confidential Not For Distribution
7 Inclusive approach has driven performance improvements Collaboration and input from key corporate stakeholders results in less variability through system standards, formulary development, and increased compliance 7 Confidential Not For Distribution
8 Supply Expense as a % of Total Operating Revenue Fiscal Year % of Total Operating Revenue % % % % % % % 8 Confidential Not For Distribution
9 Adding to Community Benefit Managing Resources is a cornerstone of providing community benefit CHRISTUS examines every piece of the supply chain for opportunities Pharmacy Indigent drug recovery program from manufacturers 340B Program Community grants for local outreach programs 9 Confidential Not For Distribution
10 Implementing a System-wide 340B Program Sam Colletti, RPh Director of Enterprise Accounts- CHRISTUS Health Broadlane
11 340B Drug Pricing Program The initial barriers to hospital pharmacy Awareness Fear of Federal Audits and Regulation Program created in 1992 Provides discounts on outpatient drugs to various covered entities Manufacturers that participate in Medicaid must sign an agreement to participate in 340B Drug Pricing Program
12 340B Covered Entities HRSA Grantees CHC, HTC, RW CDC Grantees STD, TB Family Planning Clinics Urban 638 Tribal Programs Federally Qualified Health Center (FQHC) Look-A-likes Disproportionate Share Hospitals (DSH)
13 PPS Hospitals* with a Disproportionate Patient Percentage Ratio Greater than and Core Based Statistical Areas (CBSAs), 2004 RURAL DSH HOSPITALS Alaska and Hawaii not to scale Metropolitan Status (# of Counties) Hospitals by Type of Control (# of Hospitals) Sources: US Census Bureau, 2003; CMS Provider Specific File, 2004; CMS OSCAR File, Produced By: North Carolina Rural Health Research and Policy Analysis Center, Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill. Metropolitan (1090) Micropolitan (690) Neither (1361) For Profit (79) Government (175) Non-profit (193) *Note: Only hospitals outside of metropolitan counties are included. Hospitals are mapped to the ZIP code centroid. TOTAL - 447
14 Additional Eligibility Requirements In addition to meeting the 340B DSH Adjustment Percentage requirement (>11.75%), a rural hospital Must be a public hospital owned or operated by a unit of State or local government OR Must be a private, non-profit hospital under contract with a State or local government to provide health care services to low income individuals not eligible for Medicare or Medicaid Must not purchase outpatient drugs through a Group Purchasing Organization Applies to covered patients only. Facility may utilize a GPO for other patients.
15 Why Participate in 340B? Cost savings of 20%-50% on outpatient drug purchases Option to purchase outpatient drugs below 340B prices through participation in the 340B Prime Vendor Program (PVP) Option to negotiate reduced prices for inpatient drugs (Current healthcare legislation pending.) Pricing typically 20-25% below negotiated GPO prices. Oncology drugs often 30-40% below GPO prices.
16 What Drugs Are Covered? Covered drugs: Outpatient Prescription drugs (includes hospital outpatient areas such as ER, OP OR, cancer centers, infusion centers, etc.) Over-the-counter drugs (if accompanied by a written prescription) Non-covered drugs: Vaccines Drugs given to the patient in inpatient care settings (limited exception pricing offered by manufacturers through the prime vendor program.)
17 Estimated Prices For Selected Public Purchasers, as % Average Wholesale Price 0% 20% 40% 60% 80% 100% AWP 100.0% AMP 80.0% Medicaid (Min.) Medicaid Net FSS 340B FCP 67.9% 60.5% 51.7% 49.0% 47.9% Private Sector Pricing VA Contract 34.6% Stephen Schondelmeyer, PRIME Institute, University of Minnesota (2001)
18 Savings may be used to: serve more patients expand formulary expand services subsidize prescriptions
19 Contact hospital s Finance Dept. to obtain Disproportionate Share Adjustment Percentage If >11.75% (based on most recent cost reporting period) Download 340B registration forms If < 11.75% PUBLIC HOSPITALS 340 Program Enrollment Letter PRIVATE NON-PROFIT HOSPITALS STOP HERE! Ineligible for 340B Supporting documentation: Verify state/local Government owned/operated Certification of contract with state/local government Submit all forms to: HRSA/HSB/OPA Mail Stop 10C Fishers Lane Rockville, MD Certification of non-participation in GPO
20 Technical Assistance (Key web sites) HRSA Office of Pharmacy Affairs 340B Prime Vendor Program Safety Net for DSH ( Advocacy Organization) CHRISTUS is a member of the Safety Net organization.
21 CHRISTUS Implementing a System-Wide 340B Program as a Strategic Sourcing Initiative
22 Pre-2000 CHRISTUS Initially each facility/region attempted to qualify independently at the direction of the finance department. Only 3/19 facilities had attempted to qualify. No acknowledgement of the supply chain opportunity. Project Initiation After identifying the need for a centralized group effort directed by pharmacy instead of finance the group qualified 15/19 facilities. Two facilities subsequently lost qualification due to patient mix for several quarters after recent hurricanes. With requalification and acquisitions CHRISTUS now has 19/24 facilities qualified.
23 340B Facility Assessment and Enrollment Business Case: Currently CHRISTUS facilities either qualify or have high potential for DSH enrollment. Based on Broadlane's support and assistance, attempts to enroll the following CHRISTUS facilities will provide cost effective opportunities for the pharmacy programs. Only 3/18 facilities are enrolled at initial evaluation. Benefit Analysis: Contract/Initiative Description Contract Strategy Effective Date 340B Enrollment Support Achieve best outpatient pricing scenario Annualized Outpatient Spend Projected Impact of 340B Program Annualized Increase / (Decrease) to spend 1/1/06 $35,000,000 $9,800, % Implementation Timeline / Milestones / Next Steps: All potential facilities(15/19) have qualified as of March 31,2007. Only CHRISTUS St John s, CHRISTUS St Catherine s, CHRISTUS St Patrick s, and CHRISTUS St Michael s do not have sufficient indigent care to qualify at this time. 19/22 potential facilities are qualified as of June Potential Barriers to Implementation & Recommended Solution Addition of web based software needed for program management. Overly conservative financial calculations by finance departments. Low level of understanding of the federal program by facilities and the potential impact Staff training needs Financial, clinical, pharmacy data interface requirements. Owners: Sam Colletti, BL Pharmacy SLD, Steve Pitzer, CHRISTUS Executive Sponsor
24 Involvement CHRISTUS Departments Pharmacy, Finance, IT, Social Services, Business Office, Outpatient Services, Corporate Compliance, Corporate Supply Chain Executive Outside Groups GPO( Broadlane) Wholesaler ( McKesson, PHS) Organizations/ Advocacy SNAPHA( Safety Net for Pharmaceutical Access) 340B Prime Vendor Program
25 Management and Support Tools CHRISTUS currently has enrolled the entire IDN in SNAPHA, an advocacy group for 340B hospitals which provides assistance in managing the program, legal services, and lobbying efforts. CHRISTUS currently utilizes a single program management software solution provided by their wholesaler to provide virtual inventory management, product ordering and audit trails at each 340B qualified facility. CHRISTUS initially added additional consultants with specific expertise in 340b program development. Monitoring and coordination of efforts by GPO consulting staff and Corporate Executive Sponsor.
26 CHRISTUS Health Previous State 3/19(16%) potential DSH entities qualified No local or system evaluation Annualized Savings under DSH = $2,200,000 Current State 19/24(80%) potential DSH entities qualified 3 entities pending evaluation 2 will not qualify due to local demographics. System Total Drug Spend= $128,000,000 System Outpatient Spend (DSH eligible) = $37,000,000 FY09 Annual Savings under DSH = $9,500,000
27 Results Change from 16% of all facilities participating in the program to 80% of all facilities. System wide standard for management of the program and compliance with federal regulations. Significant Improvement in profitability of outpatient infusion and oncology services across the system. Significant increase in Community Outreach services without degrading business models.
The PHS 340B Drug Pricing Program
340B DRUG PRICING PROGRAM: Improving access to affordable medications. Harry P. Hagel, RPh, MS Senior Director HRSA Pharmacy Services Support Center American Pharmacists Association August 16, 2006 The
More informationThe 340B Drug Pricing Program: The Basics
The 340B Drug Pricing Program: The Basics Paul Shank, MBA Health & Human Services Consultant, Health Resources and Services Administration Healthcare Systems Bureau, Office of Pharmacy Affairs July 14,
More information340B Drug Pricing Program January 15, 2015
340B Drug Pricing Program January 15, 2015 340B Basics - Gary Merchant. MBA, BSPharm 340B Audit - Robert Theriault, MBA, BSPharm Declarations Neither Gary Merchant nor Robert Theriault have no actual or
More informationThe 340B Drug Pricing Program: The Basics INTEGRITY ACCESS VALUE 1
The 340B Drug Pricing Program: The Basics INTEGRITY ACCESS VALUE 1 Learning Objectives 1 2 3 Intent of the program 340B Pricing determination Entity eligibility 4 5 6 Program requirements and prohibitions
More informationHRSA Pharmacy Services Support Center: The 340B Access Resource
HRSA Pharmacy Services Support Center: The 340B Access Resource Lisa Scholz PharmD, MBA Vice President, APhA HRSA Pharmacy Services Support Center Office of Population Affairs Webinar 9/16 INTEGRITY ACCESS
More information340B Drug Pricing Program
340B Drug Pricing Program Chad E. Gay Director of Contract Compliance Agenda Discuss the 340B drug pricing program How the program is defined Who is eligible Enrollment Dates to be aware of Source Documentation
More informationMaximizing the 340B Drug Discount Program: A Webinar for Finance Executives in 340B Hospitals Webinar
Maximizing the 340B Drug Discount Program: A Webinar for Finance Executives in 340B Hospitals Webinar January 20, 2010 The Webinar Will Begin Momentarily National Association of Public Hospitals and Health
More informationThe 340B Drug Pricing Program. Ariel Winter and Daniel Zabinski November 6, 2014
The 340B Drug Pricing Program Ariel Winter and Daniel Zabinski November 6, 2014 Outline Background on 340B program Program has grown substantially 340B statute does not define key terms, allows many providers
More informationUPDATES ON 340B 2011. Where do we go from here?
UPDATES ON 340B 2011 Where do we go from here? Brief Review of 340B Initiated during Clinton administration Who can participate? (FQHC, Family Planning, Ryan White, Black lung, Hemophilia, Urban Indian,
More informationFederal 340B Drug Pricing Program
2015 CliftonLarsonAllen LLP Federal 340B Drug Pricing Program March 6, 2015 Continuous learning in action Learning Objectives Explain the intent of the Federal 340B Drug Pricing Program List the eligibility
More information340B Drug Discount Program Overview and Emerging Issues
340B Drug Discount Program Overview and Emerging Issues I. APPLICABLE STATUTE AND OTHER LEGAL AUTHORITIES Section 340B of the Public Health Service Act (42 U.S.C. 256b) requires pharmaceutical manufacturers,
More information340B Drug Pricing Program Results of a Survey of Eligible but Non-Participating Rural Hospitals
340B Drug Pricing Program Results of a Survey of Eligible but Non-Participating Rural Hospitals A Joint Publication of The North Carolina Rural Health Research & Policy Analysis Center (1) Working Paper
More information340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013
340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013 1 Agenda 340B Program Overview Why HRSA Audits? What will HRSA Audits Cover? Verification of Eligibility: Covered Entity,
More information340B Drug Pricing Program 340B Contract Pharmacy
340B Drug Pricing Program 340B Contract Pharmacy LTJG Enudio Mercado-Gonzalez, USPHS Program Management Officer U.S. Department of Health and Human Services Health Resources and Services Administration
More informationThe 340B Program: New Developments and New Opportunities for CAHs and Others. Todd Nova Hall Render
The 340B Program: New Developments and New Opportunities for CAHs and Others Todd Nova Hall Render Wisconsin Office of Rural Health Hospital Finance Workshop August 30, 2011 What We Will Cover 2 340B Program
More informationDisclosure. Overview. Safety Net Hospitals for Pharmaceutical Access
340B: Issues and Opportunities in Pharmacy Automation Safety Net Hospitals for Pharmaceutical Access Executive Director, SNHPA Editor in Chief, Drug Discount Monitor American Society for Automation in
More information2015-340B & Prime Vendor Program Update
2015-340B & Prime Vendor Program Update Christopher A. Hatwig, R.Ph., MS, FASHP President, Apexus 340B Sales by Entity Types Percentage of Total Apexus Participant Sales 90.00% 80.00% 70.00% 60.00% 50.00%
More informationCPAs and ADVISORS. experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS
CPAs and ADVISORS experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS BRIAN M. BELL BRAD K. BROTHERTON DIRECTOR PARTNER MATERIALS COVERED TODAY 340B Program Evolution, Purpose & Benefits
More informationPHARMACY CARE ----- FQHCs AND 340B PROGRAM
PHARMACY CARE ----- FQHCs AND 340B PROGRAM HISTORY OF 340B PROGRAM Initiated during Clinton administration Who can participate? FQHC, Family Planning, Ryan White, Black Lung, Hemophilia, Urban Indian,
More information10/1/2013. Objectives. 340B Drug Pricing Program; Transitioning from Access to Integrity. 340B Stats, Arkansas. 340B Participating Entities, AR
Objectives Drug Pricing Program; Transitioning from Access to Integrity Arkansas Association of Health-system Pharmacists 47 th Annual Fall Seminar October 3 & 4, 2013 Chris Hatwig RPh, MS, FASHP President,
More informationThe 340B Drug Pricing Program: The Basics
The 340B Drug Pricing Program: The Basics Todd Lemke, Pharm.D CDE Paynesville Area Health Care System Pharmacist HRSA APhA Pharmacy Services Support Center Consultant 1 Intent of the 340B Program Safety
More informationXXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management
340B XXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management 800.473.3516 www.wellpartner.com Table of Contents 340B Fundamentals for Health System Executive Management...1 What
More information340B Drug Discount Program Identifying risks and internal audit focus areas
340B Drug Discount Program Identifying risks and internal audit focus areas Introduction The 340B Drug Discount Program is administered by the Health Resources and Services Administration (HRSA) Office
More information340B Drug Discount Program 2013 March 15, 2013 1 Agenda 340B Program Overview Covered Entities Covered Drugs Covered Patients Why HRSA Audits How to Prepare for HRSA Audit Questions/Answers 2 340 DRUG
More information340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready. Suzanne Herzog Founding Director Rx X Consulting
340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready Suzanne Herzog Founding Director Rx X Consulting What is 340B? 340B Overview A drug discount program that allows covered
More informationFinally... maybe? The Long Awaited 340B Mega Guidance. Georgia Healthcare Financial Management Association. October 2015
Finally... maybe? The Long Awaited 340B Mega Guidance Georgia Healthcare Financial Management Association October 2015 Disclaimer This webinar assumes the participant is familiar with the basic operations
More informationThe 340B Drug Discount Program Overview, Compliance Issues and Interplay with Medicare and Medicaid
The Drug Discount Program Overview, Compliance Issues and Interplay with Medicare and Medicaid Barbara Straub Williams Powers Pyles Sutter & Verville PC American Health Lawyers Association 2014 Institute
More informationSpeakers. Recent Developments in 340B Drug Pricing Program Compliance and Enforcement. Elizabeth S. Elson, Esq. Anil Shankar, Esq.
1 Recent Developments in 340B Drug Pricing Program Compliance and Enforcement Elizabeth S. Elson, Esq. Anil Shankar, Esq. October 18, 2012 2 Speakers Elizabeth Elson Of Counsel Foley & Lardner LLP Los
More informationOverview of Drug Pricing for Public Programs
Overview of Drug Pricing for Public Programs 1 J U L I E C R O S S, I N D E P E N D E N T C O N S U L T A N T A N N E D O N N E L L Y, P R O J E C T I N F O R M A N D F A I R P R I C I N G C O A L I T
More informationAlabama Department of Public Health Drug Purchasing Programs: 340B and MMCAP. Alabama Department of Public Health 8/20/2012
Alabama Department of Public Health Drug Purchasing Programs: 340B and MMCAP Satellite Conference and Live Webcast Thursday, August 23, 2012 2:00 4:00 p.m. Central Time Produced by the Alabama Department
More informationOctober 27, 2015. Attention: RIN 0906-AB08. RE: 340B Drug Pricing Program Omnibus Guidance. Dear Captain Pedley:
Captain Krista Pedley, Director Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane Mail Stop 08W05A Rockville, MD 20857 Attention: RIN 0906-AB08 RE: 340B Drug Pricing
More informationKeep Your Savings: 340B Audits and Ensuring Compliance
Keep Your Savings: 340B Audits and Ensuring Compliance Disclosure This presentation reflects experience with the topics at hand and does not constitute legal advice, and does not reflect interpretation
More information4/3/2015 WHAT IS 340B? DISCLOSURE. No conflicts of interest to disclose
WHAT IS 340B? S C O T T M I L N E R P H AR M D, M B A DISCLOSURE No conflicts of interest to disclose 1 OBJECTIVES At the end of this presentation we should be able to: Describe the origin of the 340b
More informationThe Pharmacy 340B Program- Compliance & Internal Audit Strategies. for Covered Entities. Matthew D. Vogelien Huron Healthcare
The Pharmacy 340B Program- Compliance & Internal Audit Strategies Matthew D. Vogelien Huron Healthcare for Covered Entities 340B Drug Discount Program (340B Program) Discussion Outline Topics for Discussion:
More informationMEDICARE PART B DRUGS. Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
United States Government Accountability Office Report to Congressional Requesters June 2015 MEDICARE PART B DRUGS Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
More informationThe 340B Drug Discount Program
The 340B Drug Discount Program Ponaman Healthcare Consulting Ralph V. Moreno Jr. Presented: August 11, 2011 Table of Contents...1 THE 340B DRUG DISCOUNT PROGRAM 1.1 340B Overview......2 1.2 340B Eligibility.......
More informationASHP Regulatory Alert
Proposed Guidance: 340B Drug Discount Program Introduction On Friday, August 28, 2015, the Health Resources and Services Administration (HRSA) published the long awaited proposed omnibus guidance for the
More information340B Drug Pricing Program: Overview and Recent Developments
340B Drug Pricing Program: Overview and Recent Developments November 12, 2015 Kirstin B. Ives Partner and Chair of Healthcare Litigation Group Williams Montgomery & John Ltd. 233 S. Wacker Drive, Suite
More information340B Drug Pricing Program. A Survey of the Program s Past, Present, and Future
340B Drug Pricing Program A Survey of the Program s Past, Present, and Future Presented by: Daniel Soldato Wyatt, Tarrant & Combs LLP dsoldato@wyattfirm.com (859) 288-7631 Disclaimer The views expressed
More information340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY
CPAs & ADVISORS experience clarity // 340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY September 17, 2014 Michael Earls, CPA, Senior Manager September 17, 2014 OVERVIEW OF TODAY S PRESENTATION
More informationHemophilia Treatment Center Manual for Participating in the Drug Pricing Program Established by Section 340B of the Public Health Service Act
Hemophilia Treatment Center Manual for Participating in the Drug Pricing Program Established by Section 340B of the Public Health Service Act July 2005 Table of Contents Introduction 4 Part I: Major Elements
More informationGAO DRUG PRICING. Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement
GAO United States Government Accountability Office Report to Congressional Committees September 2011 DRUG PRICING Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs
More information340B DISCOUNT DRUG PROGRAM OVERVIEW
340B DISCOUNT DRUG PROGRAM OVERVIEW March 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which
More information340B Drug Pricing Program: Recent Developments and Compliance Update
340B Drug Pricing Program: Recent Developments and Compliance Update Elizabeth S. Elson, Esq. Anil Shankar, Esq. November 19, 2015 Attorney Advertising Prior results do not guarantee a similar outcome
More information340B Drug Pricing Program Results of a Survey of Participating Hospitals
340B Drug Pricing Program Results of a Survey of Participating Hospitals A Joint Publication of The NORC Walsh Center for Rural Health Analysis (1) Working Paper #2007-03 And The North Carolina Rural Health
More informationSUMMARY: The Health Resources and Services Administration (HRSA) administers section
This document is scheduled to be published in the Federal Register on 08/28/2015 and available online at http://federalregister.gov/a/2015-21246, and on FDsys.gov Billing Code: 4165-15 DEPARTMENT OF HEALTH
More information340B program presents opportunities and challenges
NOVEMBER 2009 healthcare financial management MEDICARE/MEDICAID Christopher L. Keough Stephanie A. Webster 340B program presents opportunities and challenges AT A GLANCE > The 340B program provides an
More information(RIN) 0906-AB08; 340-B
October, 2015 Ms. Krista Pedley Director, Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) 5600 Fishers Lane, Mail Stop 08W05A Rockville, Maryland 20857 Re: Regulatory
More informationOverview of the 340B Drug Pricing Program
M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program 425 I Street, NW Suite 701 Washington, DC 20001
More informationC. Covered 340B drugs, as found in section 1927 (k)(2) of the Social Security Act, include the following outpatient drugs:
Title 23: Medicaid Part 200: General Provider Information Part 200 Chapter 4: Provider Enrollment Rule 4.10: 340B Providers A. The Division of Medicaid defines a 340B provider as a nonprofit healthcare
More informationEligibility of Rural Hospitals for the 340B Drug Discount Program
Public Hospital Pharmacy Coalition www.phpcrx.org (A Coalition of the National Association of Public Hospitals and Health Systems) Eligibility of Rural Hospitals for the 340B Drug Discount Program Prepared
More informationThe 3 Keys to Success in Your 340B Program. Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company
The 3 Keys to Success in Your 340B Program Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company Objectives Provide a description and overview of the 340B program Discuss
More informationMega Guidance Is Here!
Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. 1 Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are
More informationMega Guidance Is Here!
Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are we
More information340B Benefits Some, Not Others
340B Benefits Some, Not Others Money Redirected Through Expansion By Ron Schleif, Bruce Edelen, and Mary Lou Bowers Recent legislative and marketplace changes are considerably increasing the impact 340B
More informationThe Federal 340B Drug Discount Program: A Primer
The Federal 340B Drug Discount Program: A Primer Andrea G. Cohen Manatt, Phelps & Phillips, LLP Presentation to the National Medicaid Congress June 4, 2006 Preview 340B Program Overview What is it Who
More informationSECTION 12 - REIMBURSEMENT METHODOLOGY
SECTION 12 - REIMBURSEMENT METHODOLOGY 12.1 THE BASIS FOR ESTABLISHING A RATE OF PAYMENT...2 12.2 DETERMINING A FEE...2 12.2.A LONG-TERM CARE DISPENSING FEE REQUIREMENTS...3 12.3 MEDICARE/MEDICAID REIMBURSEMENT
More informationSafety Net Hospitals for Pharmaceutical Access
Safety Net Hospitals for Pharmaceutical Access December 24, 2008 Ms. Alberta J. Dwivedi Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1404-FC Mail Stop
More informationHealth IT Policy Committee Meeting. Data Update. March 10, 2015
Health IT Policy Committee Meeting Data Update March 10, 2015 Agenda Examine characteristics associated with meaningful use performance among eligible hospitals Care transitions Patient engagement Patient
More informationOPA DATABASE GUIDE PUBLIC USERS - RECERTIFICATION FOR AUGUST 2013 VERSION 5.2.1
OPA DATABASE GUIDE FOR PUBLIC USERS - RECERTIFICATION AUGUST 2013 VERSION 5.2.1 CERTIFICATION 1 Authorizing Official (AO) Advance Notification 1 340B Recertification Email 2 AO Logging In 3 Navigating
More informationDate: September 3, 2014
Date: September 3, 2014 Subject: Background on Sections 401 and 403 of the Indian Health Care Improvement Act: Disregarding Certain Payments in Determining Appropriations and Reporting Requirements Note:
More information340B Policy Landscape
340B Policy Landscape Providence 2015 340B Summit Presented by Steve Brennan, Director, Public Policy Providence Health & Services Sept. 28, 2015 1 Today s topics Backdrop of debate over 340B program Legislative
More informationThe Bridge to 340B Comprehensive Pharmacy Services Solutions in Underserved Populations
The Bridge to 340B Comprehensive Pharmacy Services Solutions in Underserved Populations Information and Tools for Decision Makers Prepared for Medpin by Katheryne Richardson, PharmD April 2004 The Bridge
More informationEnsuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability
Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability Fern Paul-Aviles, PharmD, MS, BCPS Director, 340B and Ambulatory Regulatory Program Compliance Carolinas Healthcare
More information340B University Page 1 340B Manager and Coordinator Job Description Template
340B University Page 1 Purpose: The purpose of this tool is to provide a list of activities commonly assigned to the role of 340B Manager or Coordinator. This list is not exhaustive, rather a compilation
More informationStructuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements
Presenting a live 90-minute webinar with interactive Q&A Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements THURSDAY, JUNE 4, 2015 1pm Eastern 12pm Central 11am
More informationThe Medicaid EHR Incentive Program: Overview, Program Integrity & Compliance
Medicaid EHR Incentive Program The Medicaid EHR Incentive Program: Overview, Program Integrity & Compliance Martin Thies, PhD, CIA Health IT Program Integrity Manager Medicaid Purchasing Administration
More information340B UNIVERSITY Las Vegas Edition. May 31, 2014
340B UNIVERSITY Las Vegas Edition May 31, 2014 SESSION 1: THE TOP 5: 340B BASICS FOR HOSPITALS Mike Benedict Objectives 1. Define the intent of the 340B Program 2. Describe the major 340B stakeholders
More informationPharmaceutical Marketplace Dynamics Expenditures, Distribution, Coverage, Pricing
Pharmaceutical Marketplace Dynamics Expenditures, Distribution, Coverage, Pricing John M. Coster, Ph.D., R.Ph. National Association of Chain Drug Stores Presented at National Health Policy Forum Session,
More informationOctober 9, 2015. RIN 0906-AB08 340B Drug Pricing Program Omnibus Guidance. Dear Director Pedley:
October 9, 2015 Krista Pedley Director, Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane Mail Stop 08W05A Rockville, Maryland 20857 Re: RIN 0906-AB08 340B Drug
More informationPrescription drugs are a critical component of health care. Because of the role of drugs in treating conditions, it is important that Medicare ensures that its beneficiaries have access to appropriate
More informationkaiser medicaid commission on and the uninsured May 2009 Community Care of North Carolina: Putting Health Reform Ideas into Practice in Medicaid
P O L I C Y B R I E F kaiser commission on medicaid SUMMARY and the uninsured Community Care of North Carolina: Putting Health Reform Ideas into Practice in Medicaid May 2009 Why is Community Care of North
More informationCOST OF DISPENSING PRESCRIPTION DRUGS TO MEDICAID MEMBERS SURVEY
COST OF DISPENSING PRESCRIPTION DRUGS TO COLORADO DEPARTMENT OF HEALTH CARE POLICY AND FINANCING JULY 13, 2015 CONTENTS 1. Survey overview... 1 Purpose of this survey... 1 Applicability... 1 How to submit
More information340B GROWTH AND THE IMPACT ON THE ONCOLOGY MARKETPLACE
340B GROWTH AND THE IMPACT ON THE ONCOLOGY MARKETPLACE Healthcare WHITE PAPER SEPTEMBER 2015 Prepared By: Aaron Vandervelde avanvervelde@thinkbrg.com 202.480.2661 Copyright 2015 by Berkeley Research Group,
More informationLEGISLATIVE AUDITOR VIRGINIA WEST. Department of Health and Human Resources. Full Performance Evaluation PERFORMANCE EVALUATION AND RESEARCH DIVISION
LEGISLATIVE AUDITOR PERFORMANCE EVALUATION AND RESEARCH DIVISION WEST VIRGINIA Full Performance Evaluation Department of Health and Human Resources The Department of Health and Human Resources Has Made
More informationMaterials Management Overview
Partners HealthCare Overview Materials Management Overview Procurement Activity ACA Impact on Procurement 2 3 PARTNERS HEALTHCARE OVERVIEW Partners HealthCare System Incorporated was founded in 1994 by
More informationSubject: Electronic Health Records: Number and Characteristics of Providers Awarded Medicaid Incentive Payments for 2011
United States Government Accountability Office Washington, DC 20548 December 13, 2012 Congressional Committees Subject: Electronic Health Records: Number and Characteristics of Providers Awarded Medicaid
More information340B DRUG DISCOUNT PROGRAM OMNIBUS GUIDANCE. Presented by the American Bar Association Health Law Section and Center for Professional Development
340B DRUG DISCOUNT PROGRAM OMNIBUS GUIDANCE Presented by the American Bar Association Health Law Section and Center for Professional Development American Bar Association Center for Professional Development
More informationWhen Public Payment Declines, Does Cost-Shifting Occur? Hospital and Physician Responses. November 13, 2002 Washington, DC
When Public Payment Declines, Does Cost-Shifting Occur? Hospital and Physician Responses November 13, 2002 Washington, DC These materials were commissioned by the Robert Wood Johnson Foundation for use
More informationToday s Agenda. Statement of Conflicts of Interest 7/9/2015
Geri Brennan Assistant Director, Health Care United States Government Accountability Office Statement of Conflicts of Interest Geri Brennan has no actual or potential conflict of interest in relation to
More informationExpanding 340B Participation: The Provider-Based Challenge
Expanding 340B Participation: The Provider-Based Challenge Presentation by Karen Smith, Esq. & David Johnston, Esq. Bricker & Eckler LLP www.bricker.com Columbus l Cleveland l Cincinnati-Dayton I Marietta
More informationWho we are and what we do
Medical Education in North Carolina: What is the Return on Investment? Julie Spero, MSPH Erin Fraher, PhD MPP Who we are and what we do Program on Health Workforce Research & Policy Cecil G. Sheps Center
More informationHB 686-FN-A - AS INTRODUCED. establishing a single payer health care system and making an appropriation therefor.
0 SESSION -0 0/0 HOUSE BILL AN ACT -FN-A establishing a single payer health care system and making an appropriation therefor. SPONSORS: Rep. McNamara, Hills ; Rep. Suzanne Smith, Graf ; Rep. Moody, Rock
More informationHow Health Reform Will Change the Supply Chain
How Health Reform Will Change the Supply Chain Panelists: Steve Pitzer, System Director Supply Chain, CHRISTUS David McCombs, VP, ERP/Supply Chain Operations, Bon Secours Health System, Inc. Mike Cassady,
More informationChallenges and Opportunities
The Future of the 340B Drug Pricing Program: Challenges and Opportunities Jeffrey R. Lewis jeffreyrobertlewis@gmail.com Mr. Lewis is the former President of PS2 Health Care and now serves as the Chief
More informationSubject: Electronic Health Records: Number and Characteristics of Providers Awarded Medicare Incentive Payments for 2011
United States Government Accountability Office Washington, DC 20548 July 26, 2012 Congressional Committees Subject: Electronic Health Records: Number and Characteristics of Providers Awarded Medicare Incentive
More informationDivision of Behavioral Health. Provider Agency Requirements Information Resources for Providers
Division of Behavioral Health Provider Agency Requirements Information Resources for Providers 1 Community Behavioral Health Services (CBHS) Grantee Provider Agency Requirements Must meet requirements
More informationregulatory and reimbursement Expansion
regulatory and reimbursement Expansion 24 managedcareoncology Quarter 4 2010 of Section 340B Raises New Questions for Cancer Stakeholders by Bryan Cote One of the benefits of the new healthcare reform
More informationCMS Medicine Dish Shows
CMS Medicine Dish Shows October 19, 2011: "Medicare Part D and Program Updates IHS and CMS experts discussed Medicare Part D and recent Medicare program changes: New dates for Open Enrollment Creditable
More informationRE: 340B Drug Pricing Program Omnibus Guidance HRSA RIN 0906-AB08, (Vol. 80, No. 167, August 28, 2015)
October 26, 2015 Krista Pedley, PharmD, MS Captain, USPHS Director, Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane, Mail Stop 08W05A Rockville, MD 20857 Via Email:
More informationCONGRESS OF THE UNITED STATES CONGRESSIONAL BUDGET OFFICE
CONGRESS OF THE UNITED STATES CONGRESSIONAL BUDGET OFFICE A CBO PAPER JUNE 2005 Prices for Brand-Name Drugs Under Selected Federal Programs Royalty-free/Corbis A CBO PAPER Prices for Brand-Name Drugs
More informationMedical Care Advisory Committee. Andy Vasquez, Deputy Director, Medicaid/CHIP Vendor Drug Program Health and Human Services Commission
TO: Medical Care Advisory Committee DATE: November 8, 2013 FROM: Andy Vasquez, Deputy Director, Medicaid/CHIP Vendor Drug Program Health and Human Services Commission Agenda Item No.: 7 SUBJECT: Fee-for-Service
More informationReport No.: 99-00057-4 Date: December 20, 2000. Office of Inspector General Washington DC 20420
AUDIT OF VETERANS HEALTH ADMINISTRATION (VHA) PHARMACY CO-PAYMENT LEVELS AND RESTRICTIONS ON FILLING PRIVATELY WRITTEN PRESCRIPTIONS FOR PRIORITY GROUP 7 VETERANS VHA can reduce the cost impact of providing
More informationA fter much-anticipation, the Health Resources and
BNA s Health Care Policy Report Reproduced with permission from BNA s Health Care Policy Report, 23 HCPR 1420, 09/21/2015. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
More informationCOMMUNITY MERCY HEALTH PARTNERS LIVING OUR MISSION AND VALUES. 2011 Community Benefit Report COMMUNITY MERCY. Health Partners
COMMUNITY MERCY HEALTH PARTNERS LIVING OUR MISSION AND VALUES 2011 Community Benefit Report COMMUNITY MERCY Health Partners Dear Friend, COMMUNITY MERCY Health Partners 100 Medical Center Drive Springfield,
More informationMedicaid Covered Outpatient Prescription Drug Reimbursement Information by State. Quarter Ending September 2015
Medicaid Covered Outpatient Prescription Drug Reimbursement Information by State Quarter Ending September 2015 340B=prices charged to covered entities under the Public Health Services Act, AAC=actual acquisition
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration RIN 0906-AB08 340B Drug Pricing Program Omnibus Guidance
Page 1 THOT Members AUSTIN Central Health Seton Healthcare Family CORPUS CHRISTI CHRISTUS Spohn Health System Nueces County Hospital District DALLAS Children s Health System of Texas Parkland Health &
More informationPrinted copies are for reference only. Please refer to the electronic copy of this policy for the latest version.
340B Pharmacy Audit Policy Version: 1.4 Date Created: 01/05/2015 Date Approved: 02/18/2015 Printed copies are for reference only. Please refer to the electronic copy of this policy for the latest version.
More informationMedicaid. (Title XIX and Title XXI) STATE REPORTS FY 2001. Division of Health Services Research VIRGINIA. SUK-FONG S TANG, PhD.
Medicaid STATE REPORTS FY 2001 (Title XIX and Title XXI) Text7: Division of Health Services Research SUK-FONG S TANG, PhD General Information about CMS/MSIS2082, data source of this report: (Based on CMS
More informationGROWTH OF THE 340B PROGRAM: PAST TRENDS, FUTURE PROJECTIONS
: PAST TRENDS, FUTURE PROJECTIONS Healthcare WHITE PAPER NOVEMBER 2014 Prepared By: Aaron Vandervelde avandervelde@thinkbrg.com 202.480.2661 Copyright 2014 by Berkeley Research Group, LLC. Except as may
More information